title: Durable remission after treatment with very low doses of imatinib for FIP1L1-PDGFRα-positive chronic eosinophilic leukaemia.
authors.forename: Grzegorz
authors.initials: G
authors.lastname: Helbig
authors.forename: Andrzej
authors.initials: A
authors.lastname: Moskwa
authors.forename: Marek
authors.initials: M
authors.lastname: Hus
authors.forename: Jarosław
authors.initials: J
authors.lastname: Piszcz
authors.forename: Alina
authors.initials: A
authors.lastname: Swiderska
authors.forename: Alina
authors.initials: A
authors.lastname: Urbanowicz
authors.forename: Małgorzata
authors.initials: M
authors.lastname: Całbecka
authors.forename: Ilona
authors.initials: I
authors.lastname: Seferyńska
authors.forename: Małgorzata
authors.initials: M
authors.lastname: Raźny
authors.forename: Marek
authors.initials: M
authors.lastname: Rodzaj
authors.forename: Ewa
authors.initials: E
authors.lastname: Żuk
authors.forename: Sławomira
authors.initials: S
authors.lastname: Kyrcz-Krzemień
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D001549:Benzamides; D002908:Chronic Disease; D004305:Dose-Response Relationship, Drug; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D017681:Hypereosinophilic Syndrome / Q000188:drug therapy* / Q000473:pathology; D000068877:Imatinib Mesylate; D008297:Male; D008875:Middle Aged; D015514:Oncogene Proteins, Fusion / Q000235:genetics; D010879:Piperazines / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D011743:Pyrimidines / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D020796:Receptor, Platelet-Derived Growth Factor alpha / Q000235:genetics; D012074:Remission Induction / Q000379:methods; D012189:Retrospective Studies; D013163:Splenomegaly / Q000209:etiology; D013997:Time Factors; D055815:Young Adult; D039221:mRNA Cleavage and Polyadenylation Factors / Q000235:genetics
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D015514:Oncogene Proteins, Fusion; D010879:Piperazines; D011743:Pyrimidines; D039221:mRNA Cleavage and Polyadenylation Factors; D000068877:Imatinib Mesylate; C479819:FIP1L1-PDGFRA fusion protein, human; D020796:Receptor, Platelet-Derived Growth Factor alpha